Bioentrepreneur Contents: January 2017

If you are unable to see the message below, click here to view.

IMPORTANT MESSAGE: Starting March 2017 you will no longer receive E-Alerts from the Bioentrepreneur portal. To continue receiving content from Bioentrepreneur, please sign up for the Nature Biotechnology E-Alert here.

Latest Article

So you want to be a student entrepreneur? Practical tips for graduate students with an aspiration to start a life science venture.

SciCafé

Startups on the menu: Atreca

Trade Secrets Blog

The Bioentrepreneur blog, Trade Secrets, boasts contributors from around the globe, providing regular insight and commentary from those helping build the world's biotechnology sectors.

Podcast

The new episode of Nature Biotechnology's First Rounders podcast: Jeremy Levin is chairman and CEO of Ovid Therapeutics, formerly president and CEO of Teva Pharmaceutical Industries, and former member of the executive committee at Bristol-Myers Squibb, where he led that company's “string of pearls” strategy. His conversation with Nature Biotechnology covers shifting his mindset from treating patients to business development, his youth in South Africa, and how his past influences his view of the 2016 US presidential election results.

View more articles

Advertisement

BioPharma Dealmakers A supplement to Nature Biotechnology & Nature Reviews Drug Discovery Want to continue receiving updates on partnering opportunities and emerging therapeutic areas? Be sure to sign up for the BioPharma Dealmakers e-alerts Follow us on Twitter Listen to our Webinars

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department For other enquiries, please contact our customer feedback department Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.